Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
56.44
+0.44 (0.79%)
May 8, 2026, 4:00 PM EDT - Market closed
Xenon Pharmaceuticals Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$70.55
Upside
+25.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +45.29% | May 8, 2026 |
| Needham | Needham | Strong Buy Maintains $80 → $78 | Strong Buy | Maintains | $80 → $78 | +38.20% | May 8, 2026 |
| Wedbush | Wedbush | Buy Maintains $64 → $63 | Buy | Maintains | $64 → $63 | +11.62% | Mar 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $49 → $68 | Buy | Maintains | $49 → $68 | +20.48% | Mar 10, 2026 |
| Wedbush | Wedbush | Buy Maintains $47 → $64 | Buy | Maintains | $47 → $64 | +13.39% | Mar 10, 2026 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $56 → $90 | Strong Buy | Maintains | $56 → $90 | +59.46% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $53 → $74 | Strong Buy | Maintains | $53 → $74 | +31.11% | Mar 10, 2026 |
| Needham | Needham | Strong Buy Maintains $58 → $80 | Strong Buy | Maintains | $58 → $80 | +41.74% | Mar 9, 2026 |
| Baird | Baird | Buy Maintains $63 → $97 | Buy | Maintains | $63 → $97 | +71.86% | Mar 9, 2026 |
| Needham | Needham | Strong Buy Maintains $55 → $58 | Strong Buy | Maintains | $55 → $58 | +2.76% | Feb 27, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $48 → $49 | Buy | Maintains | $48 → $49 | -13.18% | Feb 27, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $60 | Buy | Initiates | $60 | +6.31% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | +9.85% | Jan 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | -14.95% | Dec 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +6.31% | Nov 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $58 | Buy | Maintains | $55 → $58 | +2.76% | Nov 4, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.